These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30988364)

  • 1. Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats.
    Drazanova E; Ruda-Kucerova J; Kratka L; Stark T; Kuchar M; Maryska M; Drago F; Starcuk Z; Micale V
    Sci Rep; 2019 Apr; 9(1):6062. PubMed ID: 30988364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
    Stark T; Di Bartolomeo M; Di Marco R; Drazanova E; Platania CBM; Iannotti FA; Ruda-Kucerova J; D'Addario C; Kratka L; Pekarik V; Piscitelli F; Babinska Z; Fedotova J; Giurdanella G; Salomone S; Sulcova A; Bucolo C; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
    Biochem Pharmacol; 2020 Jul; 177():114004. PubMed ID: 32360362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.
    Chin CL; Curzon P; Schwartz AJ; O'Connor EM; Rueter LE; Fox GB; Day M; Basso AM
    Synapse; 2011 May; 65(5):393-403. PubMed ID: 20803618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine exposure diminishes perfusion and decreases volume of sensorimotor cortex in rats.
    Drazanova E; Kratka L; Vaskovicova N; Skoupy R; Horska K; Babinska Z; Kotolova H; Vrlikova L; Buchtova M; Starcuk Z; Ruda-Kucerova J
    Pharmacol Rep; 2019 Oct; 71(5):839-847. PubMed ID: 31394417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
    Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
    Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
    O'Reilly KC; Perica MI; Fenton AA
    Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.
    Potasiewicz A; Holuj M; Litwa E; Gzielo K; Socha L; Popik P; Nikiforuk A
    Neuropharmacology; 2020 Jun; 170():108040. PubMed ID: 32165218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(I:C) model of schizophrenia in rats induces sex-dependent functional brain changes detected by MRI that are not reversed by aripiprazole treatment.
    Drazanova E; Ruda-Kucerova J; Kratka L; Horska K; Demlova R; Starcuk Z; Kasparek T
    Brain Res Bull; 2018 Mar; 137():146-155. PubMed ID: 29155259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology.
    Di Bartolomeo M; Stark T; Di Martino S; Iannotti FA; Ruda-Kucerova J; Romano GL; Kuchar M; Laudani S; Palivec P; Piscitelli F; Wotjak CT; Bucolo C; Drago F; Di Marzo V; D'Addario C; Micale V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia?
    Jongen-Rêlo AL; Leng A; Lüber M; Pothuizen HH; Weber L; Feldon J
    Behav Brain Res; 2004 Mar; 149(2):159-81. PubMed ID: 15129780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.
    Hradetzky E; Sanderson TM; Tsang TM; Sherwood JL; Fitzjohn SM; Lakics V; Malik N; Schoeffmann S; O'Neill MJ; Cheng TM; Harris LW; Rahmoune H; Guest PC; Sher E; Collingridge GL; Holmes E; Tricklebank MD; Bahn S
    Neuropsychopharmacology; 2012 Jan; 37(2):364-77. PubMed ID: 21956444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
    Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
    Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
    Takahashi K; Nakagawasai O; Sakuma W; Nemoto W; Odaira T; Lin JR; Onogi H; Srivastava LK; Tan-No K
    Neuropharmacology; 2019 May; 150():1-14. PubMed ID: 30831160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia.
    Bator E; Latusz J; Głowacka U; Radaszkiewicz A; Mudlaff K; Maćkowiak M
    Neurotox Res; 2018 Aug; 34(2):305-323. PubMed ID: 29536265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia.
    Goda SA; Olszewski M; Piasecka J; Rejniak K; Whittington MA; Kasicki S; Hunt MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():44-51. PubMed ID: 25862088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
    Featherstone RE; Rizos Z; Nobrega JN; Kapur S; Fletcher PJ
    Neuropsychopharmacology; 2007 Feb; 32(2):483-92. PubMed ID: 17035930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
    Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
    Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits.
    Fiore M; Talamini L; Angelucci F; Koch T; Aloe L; Korf J
    Neuropharmacology; 1999 Jun; 38(6):857-69. PubMed ID: 10465689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral perturbations after prenatal neurogenesis disturbance in female rat.
    Hazane F; Krebs MO; Jay TM; Le Pen G
    Neurotox Res; 2009 May; 15(4):311-20. PubMed ID: 19384565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
    Gill KM; Miller SA; Grace AA
    Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.